Pulmonary Hypertension in Thalassemia: a Call to Action

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2022 Mar 31

PMID 35357479

Authors

John C Wood

Affiliations

Soon will be listed here.

Citing Articles

Extramedullary hematopoiesis in ribs and severe pulmonary hypertension disease following intermediate beta-thalassemia: a case report.

Samadi Takaldani A, Javanshir N, Honardoost H, Negaresh M J Med Case Rep. 2023; 17(1):503.

PMID: 38066612 PMC: 10709837. DOI: 10.1186/s13256-023-04257-6.

A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.

Hopkins C, Wessel C, Chen O, El-Kersh K, Cathey D, Cave M Life Sci. 2023; 336:122289.

PMID: 38007143 PMC: 10872724. DOI: 10.1016/j.lfs.2023.122289.

Macitentan Administration for Pulmonary Hypertension Due to β-thalassemia with Multiple Organ Failure.

Takagi K, Kasai H, Tani H, Sakao S, Sugiura T, Suzuki T Intern Med. 2023; 63(11):1585-1590.

PMID: 37952959 PMC: 11189700. DOI: 10.2169/internalmedicine.2307-23.

Cardiac complications in thalassemia throughout the lifespan: Victories and challenges.

Wood J Ann N Y Acad Sci. 2023; 1530(1):64-73.

PMID: 37902424 PMC: 10841366. DOI: 10.1111/nyas.15078.

Myocardial infarction in patients with severe beta thalassaemia: a case series.

Premawardhena A, De Silva S, Rajapaksha M, Ratnamalala V, Nallarajah J, Galappatthy G Int J Emerg Med. 2023; 16(1):16.

PMID: 36894891 PMC: 9996551. DOI: 10.1186/s12245-023-00495-z.

References

Karami H, Darvishi-Khezri H, Kosaryan M, Akbarzadeh R, Dabirian M . The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension. Int Med Case Rep J. 2018; 12:1-7. PMC: 6301293. DOI: 10.2147/IMCRJ.S180602. View

Morris C, Kim H, Wood J, Porter J, Klings E, Trachtenberg F . Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 2013; 98(9):1359-67. PMC: 3762091. DOI: 10.3324/haematol.2012.082065. View

Teawtrakul N, Ungprasert P, Pussadhamma B, Prayalaw P, Fucharoen S, Jetsrisuparb A . Effect of genotype on pulmonary hypertension risk in patients with thalassemia. Eur J Haematol. 2014; 92(5):429-34. DOI: 10.1111/ejh.12261. View

Derchi G, Galanello R, Bina P, Cappellini M, Piga A, Lai M . Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study. Circulation. 2013; 129(3):338-45. DOI: 10.1161/CIRCULATIONAHA.113.002124. View

Karimi M, Borzouee M, Mehrabani A, Cohan N . Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol. 2008; 82(3):213-8. DOI: 10.1111/j.1600-0609.2008.01192.x. View